Conference item
Comparative fracture risk amongst users of different anti-osteoporosis therapies: meta-analysis of propensity-matched cohort studies using data from the Clinical Practice Research Datalink (UK) and SIDIAP (Spain).
- Abstract:
- Despite the existence of plentiful evidence on the efficacy of anti-osteoporosis drugs (AOD) to prevent fractures in randomized controlled trials, there is a need for data on their comparative effectiveness and safety in actual practice. We aimed to compare the anti-fracture effectiveness of available AODs based on the observed risk of fracture while on treatment using ‘real world’ data from the UK NHS and Spanish healthcare records.
- Publication status:
- Published
- Peer review status:
- Reviewed (other)
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 466.6KB, Terms of use)
-
- Publisher copy:
- 10.1093/rheumatology/kex061.011
Authors
- Publisher:
- Wiley
- Host title:
- BSR Rheumatology 2017
- Journal:
- Rheumatology 2017 More from this journal
- Publication date:
- 2017-04-21
- Acceptance date:
- 2017-04-01
- DOI:
- ISSN:
-
1462-0324 and 1462-0332
- Pubs id:
-
pubs:709982
- UUID:
-
uuid:0fbe6e6b-f92a-4553-8f0f-281b37c1416f
- Local pid:
-
pubs:709982
- Source identifiers:
-
709982
- Deposit date:
-
2018-02-01
Terms of use
- Copyright holder:
- Khalid et al
- Copyright date:
- 2017
- Notes:
- © The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: [email protected]. This is the accepted manuscript version of the article. The final version is available online from Oxford University Press at: http:// dx.doi.org/10.1093/rheumatology/kex061.011
If you are the owner of this record, you can report an update to it here: Report update to this record